Latest birth defects Stories
The Update on Prenatal Diagnosis and Treatment of Fetal Anomalies conference occurs in Philadelphia today through March 19 Philadelphia, PA (Vocus/PRWEB) March 16, 2011 An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects.
PHILADELPHIA, March 16, 2011 /PRNewswire-USNewswire/ -- An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects.
The U.S. Food & Drug Administration (FDA) recently issued a safety warning regarding the increased risk of birth defects in babies born to mothers that took Topamax during pregnancy.
FDA strengthens Topamax warning as medication significantly increases oral birth defects, including cleft lip and/or cleft palate, in children whose mothers took Topamax during pregnancy. Fort Lauderdale, FL (PRWEB) March 10, 2011 The Wall Street Journal reports on March 4, 2011 the FDA strengthens Topamax warning as medication significantly increases oral birth defects, including cleft lip and/or cleft palate, in children whose mothers took Topamax during pregnancy.
Thomas J. Henry Injury Attorneys urge mothers who have used Topamax, or its generic topiramate, to contact an attorney as soon as possible if their child was born with any of the following birth defects: cleft lip and/or cleft palate.
Babies being born with some very common types of birth defects have been attributed to mothers who smoke during their first trimester of pregnancy.
Maternal cigarette smoking in the first trimester was associated with a 20 to 70 percent greater likelihood that a baby would be born with certain types of congenital heart defects.
The prescription drug Depakote is currently the most prescribed branded treatment for patients with mania associated with bipolar disorder as well as for the treatment of epilepsy.
When pregnant women need medications, there is often concern about possible effects on the fetus.
The US Food and Drug Administration has issued a warning to health care professionals and patients about the potential increased risk of birth injuries and birth defects when valproate sodium and related products (e.g. Depacon, Depakote or Stavzor) are used by mothers during pregnancy.
- A hairdresser.